New Delhi, December 15, 2016: A case study from Astellas Pharma Tech Co. Ltd., Japan, describes how Cobalt’s RapID verifies the ID of raw materials through unopened paper and polyethylene sacks. Without the need to open and move containers manpower costs were reduced by more than 90% compared to existing pharmacopoeia testing methods. An additional benefit was the complete avoidance of foreign material and microbial contamination risk.
This study was part of an investigation to determine how to guarantee effective identification of packaged raw materials, in line with PIC/S GMP Annex 8 requirements. A translated excerpt of the original article, published in Japanese in the Pharm Tech Japan journal, is available for download from the Cobalt website.
Corporate Comm India(CCI Newswire)
Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…
Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…
By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…
By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …
Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…
New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…